Mark Radlinski, M.D.
NPI 1609238435 · Gastroenterology Physician · Nashville, TN
Enrolled with Medicare as Practitioner - Gastroenterology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Mark Radlinski, M.D. is a Gastroenterology Physician provider in Nashville, TN (NPI 1609238435).
Provider details
- NPI number
- 1609238435
- Entity type
- Individual
- Primary specialty
- Gastroenterology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 0101274950 (VA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
10 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
570 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Review By Radiologist of Image From Tube Placement Into Bile Duct Using an Endoscope74328 | 76 | $21 |
| Initial Hospital Care With Straightforward Or Low-Level Medical Decision Making, If Using Time, at Least 55 Minutes99222 | 60 | $118 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 55 | $15 |
| Removal of Stone Or Debris From Bile Or Pancreatic Duct Using a Flexible Endoscope43264 | 49 | $102 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 48 | $123 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Omeprazole | 39 | 18 |
| Peg3350/Sod Sulf,bicarb,cl/Kclbrand: Gavilyte-G | 21 | 20 |
| Promethazine Hcl | 17 | — |
| Lipase/Protease/Amylasebrand: Creon | 13 | — |
| Ondansetronbrand: Ondansetron Odt | 13 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$5,177 across 30 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 1215 Lee StBox 800744Charlottesville, VA 22908-0816Phone: (434) 924-1931Fax: (434) 243-5770
Registry dates
- Enumerated
- 2016-03-22
- Last updated
- 2023-06-28
- Certified
- 2023-06-28
Frequently asked questions
- What is Mark Radlinski's NPI number?
- Mark Radlinski's National Provider Identifier (NPI) is 1609238435, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Mark Radlinski's specialty?
- Mark Radlinski is listed in the NPPES registry with a primary specialty of Gastroenterology Physician (Allopathic & Osteopathic Physicians).
- Where is Mark Radlinski located?
- Mark Radlinski's practice location on file with NPPES is 3601 the Vanderbilt Clinic, Nashville, TN 37232-0816.
- What is Mark Radlinski's phone number?
- The practice phone number listed in the NPPES registry for Mark Radlinski is (615) 322-3000.
- Does Mark Radlinski accept Medicare?
- Mark Radlinski is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Mark Radlinski's NPI active?
- Yes — Mark Radlinski's NPI (1609238435) is active in the NPPES registry as of the last update on 2023-06-28.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.